A detailed history of Advisor Net Financial, Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Advisor Net Financial, Inc holds 21 shares of ZLAB stock, worth $719. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$719
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

BUY
$24.32 - $43.03 $510 - $903
21 New
21 $0
Q2 2022

Jul 07, 2022

BUY
$23.14 - $49.68 $18,512 - $39,744
800 Added 100.0%
1,600 $55,000
Q3 2020

Nov 06, 2020

BUY
$73.3 - $89.48 $58,640 - $71,584
800 New
800 $67,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.36B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.